About Axios Biosciences

About company

Axios Biosciences, spun out of the Dana-Farber Cancer Institute, is a startup company whose mission is to improve oncology drug discovery and identify drugs through a set of novel strategies and technologies, including one recently published in Nature Medicine. They are identify promising drugs that fail conventional testing methods while rejecting drugs that are destined to fail in late-stage clinical trials. We are positioned to indentify new oncology drugs in a manner never done before.